• Journal of Sasang Constitutional Medicine
• /
• v.26 no.1
• /
• pp.82-97
• /
• 2014

Objectives The purpose of this study was to survey the Personality and Ordinary Symptoms of Soyangin and to compare the tendency of their personality and symptoms according to Soyangin's major prescription. Methods 331 Soyangin's personality and ordinary symptoms data registered to SCIB(Sasang Constitutional Information Bank) were used. All data were analyzed with Chi square test. Some data were ranked and analyzed with Kruskal-Wallis test and Mann-Whitney test(with Bonferroni correction). Chi square and Kruskal-Wallis test's significant P value was 0.05. Mann-Whitney test's significant P value was 0.005. Results & Conclusions In Chi square test, there is difference in personality and symptoms in Soyangin's major prescription as followed, the degree of masculinity and femininity, the degree of patience, the condition of stool, the degree of appetite, good or bad in digesting, amount of meal, the speed of eating, amount of drinking water, the temperature of drinking water, coldness and hotness in abdomen or not. In Kruskal-Wallis test and Mann-Whitney test, Yanggyuksanhwa-tang is more masculine than Dokhwaljihwang-tang, Hyeongbangsabaek-san, Hyeongbangjihwangtang. Dokhwaljihwang-tang is less appetite than Yanggyuksanhwa-tang and Hyeongbangsabaek-san. Yanggyuksanhwa- tang is more fast in eating than Hyeongbangjihwang-tang.

• Journal of Physiology & Pathology in Korean Medicine
• /
• v.21 no.2
• /
• pp.474-478
• /
• 2007

This study evaluated effects of Yanggyuksanhwa-tang(YST) on diabetic rats. Diabetic condition in rats was induced by streptozotocin injection. Then control effect of YST was observed with changes of serum glucose, insulin, and triglyceride levels and hepatic glucokinse activity. YST treatment was resulted significant decrease of high serum glucose level of diabetic rats induced by streptozotocin at 5th day of YST treatment. YST treatment was resulted increase of low serum insulin level of diabetic rats induced by streptozotocin, but it was not significant statistically. YST treatment was resulted significant decrease of high serum triglyceride level of diabetic rats induced by streptozotocin at 3rd and 5th of YST treatment. YST treatment was resulted significant increase of low hepatic glucokinase activity of diabetic rats induced by streptozotocin at 5th day of YST treatment. These results suggest that YST has effects on serum glucose control against cerebral inchemic damage under diabetic condition.

• Journal of Physiology & Pathology in Korean Medicine
• /
• v.22 no.2
• /
• pp.321-327
• /
• 2008

This study evaluated neuroprotective effects of Yanggyuksanhwa-tang (YST) on global cerebral ischemia of diabetic rats. On primary experiment, diabetic condition in rats was induced by streptozotocin injection. Secondarily, global cerebral ischemia was induced by bilateral occlusion of the common carotid artery with hypotension (BCAO) under the diabetic condition. Then neuroprotective effect of YST was observed with changes of neuronal c-Fos and Bax expressions, and GFAP expression in the brain tissues by using immunohistochemistry. YST treatment was resulted significant decrease of c-Fos expression in CA1 hippocampus induced by BCAO on diabetic rats. YST treatment was resulted significant decrease of Bax expression in CA1 hippocampus induced by BCAO on diabetic rats. YST treatment was resulted significant decrease of c-Fos expression in cerebral cortex and caudoputamen induced by BCAO on diabetic rats. YST treatment was resulted significant decrease of GFAP expression in cerebral cortex induced by BCAO on diabetic rats. These results suggest that YST has effects on neuroprotection against cerebral ischemic damage under diabetic condition. And it is supposed that neuroprotective effect of YST reveals by anti-apoptosis mechanism.

• Journal of Physiology & Pathology in Korean Medicine
• /
• v.21 no.3
• /
• pp.741-747
• /
• 2007

This study evaluated neuroprotective effects of Yanggyuksanhwa-tang (YST), which have been known to be efficacy in the treatment of the stroke and diabetes. on focal cerebral ischemia of diabetic rats. On primary experiment, diabetic condition in rats was induced by streptozotocin injection, then, focal cerebral ischemia was induced by the middle cerebral artery occlusion (MCAO) under the diabetic condition. Then neuroprotective effect of YST was observed with changes of infarct size and volume, expressions of c-Fos, Bax, and hypoxia inducible factor (HIF)-1${\alpha}$ in the brain tissues by using 2% 2,3,5-triphenyltetrazolium chloride (TTC) staining and immunohistochemistry. YST treatment showed a significant decrease of infarct size and volume induced by MCAO in diabetic rats. YST treatment showed a significant decrease of c-Fos and Bax positive neurons in cortex penumbra. YST treatment showed a decrease of HIF-l${\alpha}$ positive neurons in cortex penumbra, but it was not significant statistically. These results suggest that YST has effects on neuroprotection against cerebral infarct under diabetic condition. And it is supposed that neuroprotective effect of YST reveals by anti-apoptosis mechanism.

• Journal of Sasang Constitutional Medicine
• /
• v.29 no.2
• /
• pp.116-127
• /
• 2017

Objectives The purpose of this study was to survey changes in symptoms caused by Sasang medicines. Methods We recruited 45 subjects who were classified 15 typical Soeumin, Soyangin, Taeumin and did a survey about symptoms. We split Soeumin into 3 groups and prescribed medicines Palmulgunja-tang, Yanggyuksanhwa-tang, Taeumjowi-tang. We did same process in Soyangin and Taeumin. After taking medicines for 4 weeks, we did a survey about physical changes. Results There was no consistent changes in symptoms. But medicines which were not suitable to their Sasang constitution induced known reactions. And medicines which were suitable to their Sasang constitution induced reactions. Conclusions Changes in symptoms appeared after taking medicine, but they can be induced by medicine.

• The Journal of Internal Korean Medicine
• /
• v.38 no.2
• /
• pp.226-234
• /
• 2017

The case of a 73-year-old Korean female with dysgeusia due to an acute left thalamic infarction is presented. The patient was treated with the herbal medicine Yanggyuksanhwa-tang, in addition to acupuncture and electronic acupuncture treatment. The filter-paper test and Oral Health Impact Profile-14, (OHIP-14) test were administered to evaluate dysgeusia. Post-treatment, the patient's dysgeusia improved. Korean medicine may be an effective treatment for dysgeusia caused by a thalamic infarction.

• Journal of Haehwa Medicine
• /
• v.26 no.1
• /
• pp.58-67
• /
• 2017

Objectives:This study was designed to report treatment by Sasang Constitutional Medicine to the patients with Major Neurocognitive Disorder(Dementia) from various causes. Methods:These two patients were diagnosed as Taeeumin and Soyangin according to the result of Sasang constitutional diagnosis, and treated by Sasang constitutional medications. The progress was evaluated with the Korean version of Mini-Mentel State Exam(KMMSE) and Global Disorientation Scale(GDS). Result:The symptoms like wandering, insomnia, cognitive disorder was improved in these patients. Also, KMMSE and GDS score were highly improved. the one patient was cured with Cheongsimyeonja-tang and and the other was cured with Jihwangbaekho-tang and Yanggyuksanhwa-tang. Conclusion:This cases show that Sasang constitutional herbal medications are an effective treatment for the patients with Major Neurocognitive Disorder.

• Journal of Sasang Constitutional Medicine
• /
• v.26 no.4
• /
• pp.400-408
• /
• 2014

Objectives The aim of this study was to report the improvement of delirium and performance status in the small-cell lung cancer patient who had multiple brain metastases and pericardial effusion after Sasang constitutional treatment. Methods We retrospectively reviewed the medical records, medical laboratory and image scans of 71-year-old male patient diagnosed as small-cell lung cancer. Results The small-cell lung cancer with multiple brain metastases patient sometimes talked deliriously even after the whole brain radiation therapy. During the hospitalization period, he showed delirium. We treated him with Gihwangbaekho-tang and Dojeokgangki-tang as a main therapy. After treatment, he didn't show delirium and performance status was improved. Conclusions A small-cell lung cancer with multiple brain metastases patient showed the improvement of symptoms (delirium, poor performance status, constipation and poor oral intake) with the treatment of Gihwangbaekho-tang, Yanggyuksanhwa-tang and Dojeokgangki-tang.

• The Journal of Internal Korean Medicine
• /
• v.40 no.6
• /
• pp.1122-1135
• /
• 2019

Purpose: The purpose of this study was to conduct a clinical analysis of patients treated for dizziness with Jeoreongchajeonja-tang, evaluate the effect of Jeoreongchajeonja-tang administration, and present indications of Jeoreongchajeonja-tang in dizziness. Methods: A retrospective study was conducted on 63 patients who were admitted to the Oriental Hospital of Se-Myung University from August 2012 to June 2019, complaining of dizziness, so who took Jeoreongchajeonja-tang. Results: 1) As a result of the analysis of the general characteristics of patients who took Jeoreongchajeonja-tang with dizziness, women were 2.7 times more than men. The age distribution was: patients in their 70s, 36.5%; in their 50s, 20.6%; in their 60s, 15.8%; and in their 80s, 12.6%. Patients had a history of hypertension (46.0%), diabetes (22.2%), stroke (17.4%), lung disease (12.6%), and cancer (11.1%). According to the diagnosis, 48 patients (76.1%) were assigned to the peripheral dizziness group, 7 patients (11.1%) to the central dizziness group, and 8 patients (12.6%) to other dizziness groups. 2) Compared with the peripheral dizziness group, the central dizziness group was older, their history of hypertension 8.4 times greater, their history of stroke 7.8 times greater, and the duration of herbal medicine administration was longer. 3) The vertigo grade was significantly decreased after taking Jeoreongchajeonja-tang (p=0.000). 4) As age increased by one year, odds ratio of improvement in the vertigo grade decreased by 0.924 times after taking Jeoreongchajeonja-tang (p=0.010). 5) Sex, disease duration, past history, diagnosis, the duration of herbal medicine administration, whether or not Yanggyuksanhwa-tang was combined with the Jeoreongchajeonja-tang and whether or not Western medicine was used did not affect improvement in the vertigo grade after taking Jeoreongchajeonja-tang. Conclusions: In patients with dizziness, Jeoreongchajeonja-tang can be used as a treatment without side effects.

• The Journal of Internal Korean Medicine
• /
• v.39 no.6
• /
• pp.1116-1135
• /
• 2018

Objective: This study was performed to research Korean medical treatment methods for hyperthyroidism by summarizing domestic clinical studies. Methods: The study was based on 14 papers published in Korea since 2000, on Korean medicine treatments for hyperthyroidism. Papers were searched on four domestic electronic databases. Results: 1. This paper analyzed 14 studies on the subject of clinical research on hyperthyroidism in Korea. 12 of them reported cases while two of them reported on clinical research. 2. The average age of the subjects was 39 years, 71.3% of women, 20-60 years of age accounted for 92%, and the average duration of disease was 22 months. 3. Of the 115 subjects, 102 had experienced Western medical treatment. So most of them chose Western medical treatment as the first treatment method, of which 24 experienced side effects. 4. Eumhuhwadong (陰虛火動) and Gieumyanghu (氣陰兩虛) appeared 3 times respectively. 5. The Korean herbal medicine, Ahnjeonbaekho-tang was the most frequent herbal medicine used to treat hyperthyroidism, with the next most frequent being Yanggyuksanhwa-tang. 6. The study, which was performed using herbal medicine alone, showed a marked improvement in clinical symptoms and thyroid function test, compared with administration of antithyroid drugs and herbal medicines. Conclusions: Large-scale studies and randomized controlled trials will be needed to evaluate the validity of Korean medical treatment for hyperthyroidism.